{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:28:28Z","timestamp":1762561708879,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004087","name":"Shizuoka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009538","name":"Council for Science Technology and Innovation","doi-asserted-by":"publisher","award":["14533567"],"award-info":[{"award-number":["14533567"]}],"id":[{"id":"10.13039\/501100009538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007172","name":"National Agriculture and Food Research Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007173","name":"Bio-oriented Technology Research Advancement Institution","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013183","name":"Swine Innovation Porc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","award":["19-25134"],"award-info":[{"award-number":["19-25134"]}],"id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009029","name":"JST Adaptable and Seamless Technology Transfer Program Through Target-driven R and D","doi-asserted-by":"publisher","award":["JPMJTM20NT"],"award-info":[{"award-number":["JPMJTM20NT"]}],"id":[{"id":"10.13039\/501100009029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Physiological Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jphyss.2025.100012","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:45:19Z","timestamp":1742280319000},"page":"100012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rebastinib inhibits FoxO1 activity and reduces dexamethasone-induced atrophy and its-related gene expression in cultured myotubes"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3044-6874","authenticated-orcid":false,"given":"Tomoki","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Kawaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9946-4697","authenticated-orcid":false,"given":"Yasuko","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuharu L.","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Ogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1407-9920","authenticated-orcid":false,"given":"Akira","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutomi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8806-9763","authenticated-orcid":false,"given":"Shinji","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jphyss.2025.100012_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.clnu.2007.03.008","article-title":"Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia","volume":"26","author":"Thomas","year":"2007","journal-title":"Clin Nutr"},{"issue":"11","key":"10.1016\/j.jphyss.2025.100012_bib2","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.bbamcr.2010.11.025","article-title":"Structural basis for DNA recognition by FOXO proteins","volume":"1813","author":"Obsil","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.jphyss.2025.100012_bib3","first-page":"2473","article-title":"The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity","volume":"116","author":"Nakae","year":"2006","journal-title":"J Clin Invest"},{"issue":"50","key":"10.1016\/j.jphyss.2025.100012_bib4","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","article-title":"FOXO transcription factors at the interface between longevity and tumor suppression","volume":"24","author":"Greer","year":"2005","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.jphyss.2025.100012_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbrc.2014.06.080","article-title":"Identification of functional glucocorticoid response elements in the mouse FoxO1 promoter","volume":"450","author":"Qin","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"24","key":"10.1016\/j.jphyss.2025.100012_bib6","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1101\/gad.208926.112","article-title":"FoxO6 regulates memory consolidation and synaptic function","volume":"26","author":"Salih","year":"2012","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.jphyss.2025.100012_bib7","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130031","article-title":"FoxO6 and PGC-1\u03b1 form a regulatory loop in myogenic cells","volume":"33","author":"Chung","year":"2013","journal-title":"Biosci Rep"},{"issue":"39","key":"10.1016\/j.jphyss.2025.100012_bib8","doi-asserted-by":"crossref","first-page":"41114","DOI":"10.1074\/jbc.M400674200","article-title":"Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch\/red muscle) fiber genes, and impaired glycemic control","volume":"279","author":"Kamei","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jphyss.2025.100012_bib9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1113\/JP273097","article-title":"FoxO-dependent atrogenes vary among catabolic conditions and play a key role in muscle atrophy induced by hindlimb suspension","volume":"595","author":"Brocca","year":"2017","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.jphyss.2025.100012_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1096\/fj.11-189977","article-title":"Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy","volume":"26","author":"Reed","year":"2012","journal-title":"Faseb J"},{"key":"10.1016\/j.jphyss.2025.100012_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1471-2407-12-265","article-title":"Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexia","volume":"12","author":"Skorokhod","year":"2012","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jphyss.2025.100012_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-018-0624-2","article-title":"Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy","volume":"11","author":"Rossari","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jphyss.2025.100012_bib13","article-title":"Phase Ib clinical and pharmacodynamic study of the TIE2 kinase inhibitor rebastinib with paclitaxel or eribulin in HER2-negative metastatic breast cancer","author":"Anampa","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.jphyss.2025.100012_bib14","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.21873\/anticanres.16428","article-title":"The suppressive effect of rebastinib on triple-negative breast cancer tumors involves multiple mechanisms of action","volume":"43","author":"Feng","year":"2023","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.jphyss.2025.100012_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/neuonc\/noz190","article-title":"DeltaNp73\/ETS2 complex drives glioblastoma pathogenesis-targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma","volume":"22","author":"Cam","year":"2020","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.jphyss.2025.100012_bib16","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1158\/1535-7163.MCT-17-0241","article-title":"The selective Tie2 inhibitor rebastinib blocks recruitment and function of Tie2(Hi) macrophages in breast cancer and pancreatic neuroendocrine tumors","volume":"16","author":"Harney","year":"2017","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.jphyss.2025.100012_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3324\/haematol.2016.152710","article-title":"Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia","volume":"102","author":"Cortes","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jphyss.2025.100012_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ccr.2011.03.003","article-title":"Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036","volume":"19","author":"Chan","year":"2011","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.jphyss.2025.100012_bib19","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1074\/jbc.M211562200","article-title":"A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells","volume":"278","author":"Komatsu","year":"2003","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.jphyss.2025.100012_bib20","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1073\/pnas.0731871100","article-title":"Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor","volume":"100","author":"Ghaffari","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"10.1016\/j.jphyss.2025.100012_bib21","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/sj.onc.1208421","article-title":"Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells","volume":"24","author":"Essafi","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jphyss.2025.100012_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17548-7","article-title":"Establishment of a system evaluating the contractile force of electrically stimulated myotubes from wrinkles formed on elastic substrate","volume":"12","author":"Hamaguchi","year":"2022","journal-title":"Sci Rep"},{"issue":"21","key":"10.1016\/j.jphyss.2025.100012_bib23","doi-asserted-by":"crossref","first-page":"12378","DOI":"10.1073\/pnas.2135217100","article-title":"PPARgamma coactivator 1beta\/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity","volume":"100","author":"Kamei","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"10.1016\/j.jphyss.2025.100012_bib24","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1021\/jm980330i","article-title":"A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation","volume":"41","author":"Abe","year":"1998","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.jphyss.2025.100012_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/acschembio.9b00724","article-title":"Imaging of Tie2 with a fluorescently labeled small molecule affinity ligand","volume":"15","author":"Koch","year":"2020","journal-title":"ACS Chem Biol"},{"issue":"3","key":"10.1016\/j.jphyss.2025.100012_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ijc.31915","article-title":"Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL\/MET","volume":"144","author":"Shen","year":"2019","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.jphyss.2025.100012_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1042\/BCJ20160941","article-title":"Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16","volume":"474","author":"Dixon-Clarke","year":"2017","journal-title":"Biochem J"},{"issue":"20","key":"10.1016\/j.jphyss.2025.100012_bib28","doi-asserted-by":"crossref","first-page":"11285","DOI":"10.1073\/pnas.1934283100","article-title":"Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation","volume":"100","author":"Matsuzaki","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.jphyss.2025.100012_bib29","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/jcb.23093","article-title":"C\/EBPbeta regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1","volume":"112","author":"Gonnella","year":"2011","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.jphyss.2025.100012_bib30","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101385RR","article-title":"FOXO1 cooperates with C\/EBPdelta and ATF4 to regulate skeletal muscle atrophy transcriptional program during fasting","volume":"36","author":"Oyabu","year":"2022","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.jphyss.2025.100012_bib31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI200420174","article-title":"Cancer cachexia is regulated by selective targeting of skeletal muscle gene products","volume":"114","author":"Acharyya","year":"2004","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jphyss.2025.100012_bib32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbagen.2017.12.015","article-title":"S-allyl cysteine inhibits TNF\u03b1-induced skeletal muscle wasting through suppressing proteolysis and expression of inflammatory molecules","volume":"1862","author":"Dutt","year":"2018","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"3","key":"10.1016\/j.jphyss.2025.100012_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jphyss.2025.100012_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.jphyss.2025.100012_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Lecker","year":"2004","journal-title":"Faseb J"},{"issue":"1","key":"10.1016\/j.jphyss.2025.100012_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2010.09.004","article-title":"Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases","volume":"143","author":"Moresi","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jphyss.2025.100012_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cmet.2011.01.001","article-title":"Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle","volume":"13","author":"Shimizu","year":"2011","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.jphyss.2025.100012_bib38","doi-asserted-by":"crossref","first-page":"E785","DOI":"10.1152\/ajpendo.00646.2007","article-title":"The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene","volume":"295","author":"Waddell","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jphyss.2025.100012_bib39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jb\/mvn126","article-title":"Effects of dimethyl sulphoxide and dexamethasone on mRNA expression of myogenesis- and muscle proteolytic system-related genes in mouse myoblastic C2C12 cells","volume":"144","author":"Nishimura","year":"2008","journal-title":"J Biochem"},{"issue":"3","key":"10.1016\/j.jphyss.2025.100012_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3177\/jnsv.64.229","article-title":"Vitamin D attenuates FOXO1-target atrophy gene expression in C2C12 muscle cells","volume":"64","author":"Hirose","year":"2018","journal-title":"J Nutr Sci Vitam"},{"key":"10.1016\/j.jphyss.2025.100012_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.ctdb.2017.10.006","article-title":"Regulation of FOXO factors in mammalian cells","volume":"127","author":"Brown","year":"2018","journal-title":"Curr Top Dev Biol"},{"issue":"6","key":"10.1016\/j.jphyss.2025.100012_bib42","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.jphyss.2025.100012_bib43","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.96.13.7421","article-title":"Protein kinase B\/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1","volume":"96","author":"Biggs","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.jphyss.2025.100012_bib44","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbamcr.2011.01.007","article-title":"Regulation of FOXO protein stability via ubiquitination and proteasome degradation","volume":"1813","author":"Huang","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.jphyss.2025.100012_bib45","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1073\/pnas.0406789102","article-title":"Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation","volume":"102","author":"Huang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.jphyss.2025.100012_bib46","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/leu.2016.51","article-title":"A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia","volume":"30","author":"Wagle","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.jphyss.2025.100012_bib47","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3892\/or.2020.7888","article-title":"Involvement of Blnk and Foxo1 in tumor suppression in BCR\u2011ABL1\u2011transformed pro\u2011B cells","volume":"45","author":"Zhang","year":"2021","journal-title":"Oncol Rep"},{"issue":"35","key":"10.1016\/j.jphyss.2025.100012_bib48","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1074\/jbc.RA119.008649","article-title":"AMPK and AKT protein kinases hierarchically phosphorylate the N-terminus of the FOXO1 transcription factor, modulating interactions with 14-3-3 proteins","volume":"294","author":"Saline","year":"2019","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jphyss.2025.100012_bib49","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1038\/s41467-024-50393-y","article-title":"Mst1-mediated phosphorylation of FoxO1 and C\/EBP-beta stimulates cell-protective mechanisms in cardiomyocytes","volume":"15","author":"Maejima","year":"2024","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.jphyss.2025.100012_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/nu14102029","article-title":"Laurel attenuates dexamethasone-induced skeletal muscle atrophy in vitro and in a rat model","volume":"14","author":"Jia","year":"2022","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.jphyss.2025.100012_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/md16120497","article-title":"Pyropia yezoensis protein prevents dexamethasone-induced myotube atrophy in C2C12 myotubes","volume":"16","author":"Lee","year":"2018","journal-title":"Mar Drugs"},{"key":"10.1016\/j.jphyss.2025.100012_bib52","article-title":"BMSC-derived exosomes inhibit dexamethasone-induced muscle atrophy via the miR-486-5p\/FoxO1 axis","volume":"12","author":"Li","year":"2021","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.jphyss.2025.100012_bib53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00585311","article-title":"The effect of hypokinesia and hypodynamia on protein turnover and the growth of four skeletal muscles of the rat","volume":"407","author":"Goldspink","year":"1986","journal-title":"Pflug Arch"},{"issue":"2","key":"10.1016\/j.jphyss.2025.100012_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.kint.2017.02.031","article-title":"The nuclear phosphatase SCP4 regulates FoxO transcription factors during muscle wasting in chronic kidney disease","volume":"92","author":"Liu","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jphyss.2025.100012_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/srep44570","article-title":"In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model","volume":"7","author":"Ikeda","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphyss.2025.100012_bib56","article-title":"Preclinical investigation of alpinetin in the treatment of cancer-induced cachexia via activating PPAR\u03b3","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharm"}],"container-title":["The Journal of Physiological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1880654625000083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1880654625000083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:24:17Z","timestamp":1762561457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1880654625000083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1880654625000083"],"URL":"https:\/\/doi.org\/10.1016\/j.jphyss.2025.100012","relation":{},"ISSN":["1880-6546"],"issn-type":[{"type":"print","value":"1880-6546"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rebastinib inhibits FoxO1 activity and reduces dexamethasone-induced atrophy and its-related gene expression in cultured myotubes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Physiological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphyss.2025.100012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The Physiological Society of Japan.","name":"copyright","label":"Copyright"}],"article-number":"100012"}}